Home Trending Stocks Why Lipocine Inc. (LPCN) Stock plunged in premarket?

Why Lipocine Inc. (LPCN) Stock plunged in premarket?

Clarus Therapeutics Defeats Lipocine’s (NASDAQ: LPCN) Patent Infringement Lawsuit On Summary JudgmentasFederal Circuit Judge William C. Bryson, granted Clarus’s motion for summary judgment against Lipocine, Inc. for failure to provide an appropriate written description of Lipocine’s asserted patent declarations. LPCN stock price plummeted adjacent to the news.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Lipocine Inc. (LPCN) shares were falling -15.33% to trade at $1.16 in premarket at last check. LPCN’s stock lost -2.14% to close Tuesday’s session at $1.37.Shares of the company fluctuated between $1.37 and $1.42 throughout the day. LPCN shares have risen by 41.24% over the last 12 months, and they have moved up by 2.24% in the past week.

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored

Read More

First Quarter Financial Report

Lipocine produced no revenue from its products in the first quarter of 2021 as well as the prior year. It reported a net loss of $3.4 million, or ($0.04) per diluted share for the first quarter 2021 versus a net loss of ($5.8) million, or ($0.14) per diluted share for the same period the previous year.

Research & development expense accumulated to be $1.58 million, reduced by 37% from $2.51 million offset by a decrease in external service provider expense for LPCN 1144 and TLANDO XR, primarily due to increment in internal personnel costs and other R&D costs.

General & administrative expenses decreased by 26% to $1.53 million from $2.08 million, offset by a reduction in legal expense linked to patent litigation with Clarus Therapeutics

As of March 31, 2021, marketable securities, capital, and equivalents accumulated to be $45.3 million, in comparison to $15.6 million per annum before. Across February 2021 amendment of the Loan and Security contract between Lipocine and Silicon Valley Bank, the $5 million minimum cash provision is no longer needed. In January 2021, Lipocine raised gross proceeds of $28.7 million via a public offering.

Lipocine continued developing the ongoing Phase II LiFT study, with 36-week biopsy data anticipated in August 2021, and additional enlistment into LiFT’s open-label extension. Lipocine is also in the process of assessing commercial options for TLANDO.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Conclusion

Lipocine Inc. (LPCN) did not induce investor interest after failing to provide an adequate written description of Lipocine’s asserted patent claims. LPCN stock price saw a substantial decrease at pre-market trading.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Aprea Therapeutics Inc. (APRE) stock soars during current market trading. What’s the update?

Aprea Therapeutics Inc. (NASDAQ: APRE) stock gained by 41.03% at the last check in the current market trading. Aprea Therapeutics is a pharmaceutical business...

Roblox Corp. (NASDAQ: RBLX) stock falls during pre-market trading session. What’s happening?

Roblox Corp. (NASDAQ: RBLX) stock gained by 2.28% at last close while the RBLX stock price declines by 8.13% in the pre-market trading session....

Can-Fite BioPharma Inc. (CANF) stock soars during current market. Why so?

Can-Fite BioPharma Inc. (NASDAQ: CANF) stock gained by 4.42% in the current market trading session. Can-Fite BioPharma Ltd. is a medication research company in...

UXIN stock surges during current market. Here’s to know why?

Uxin Ltd. (NASDAQ: UXIN) stock gains by 14.67% at last check during current market trading. In China, Uxin Limited is a prominent online used...

Opgen Inc. (OPGN) stock surged during pre-market session. What’s driving it high?

Opgen Inc. (NASDAQ: OPGN) stock declined by 1.84% at the last close whereas the OPGN stock price gains by 22.07% in the pre-market trading...

Aprea Therapeutics Inc. (APRE) stock soars during current market trading. What’s the update?

Aprea Therapeutics Inc. (NASDAQ: APRE) stock gained by 41.03% at the last check in the current market trading. Aprea Therapeutics is a pharmaceutical business...

TAL Education Group (TAL) stock is tumbling today: What’s Going on?

Shares of the TAL Education Group (TAL) stock were tumbling in the current market trading session today on June 16, 2021, without any obvious...

SPI Energy Inc. (SPI) stock surged in the current market trading. Here’s the update

SPI Energy Inc. (NASDAQ: SPI) stock soars by 15.42% during the current market trading session. SPI Energy is an international renewable energy company that...

Related News

Aprea Therapeutics Inc. (APRE) stock soars during current market trading. What’s the update?

Aprea Therapeutics Inc. (NASDAQ: APRE) stock gained by 41.03% at the last check in the current market trading. Aprea Therapeutics is a pharmaceutical business...

Roblox Corp. (NASDAQ: RBLX) stock falls during pre-market trading session. What’s happening?

Roblox Corp. (NASDAQ: RBLX) stock gained by 2.28% at last close while the RBLX stock price declines by 8.13% in the pre-market trading session....

Can-Fite BioPharma Inc. (CANF) stock soars during current market. Why so?

Can-Fite BioPharma Inc. (NASDAQ: CANF) stock gained by 4.42% in the current market trading session. Can-Fite BioPharma Ltd. is a medication research company in...

UXIN stock surges during current market. Here’s to know why?

Uxin Ltd. (NASDAQ: UXIN) stock gains by 14.67% at last check during current market trading. In China, Uxin Limited is a prominent online used...

Opgen Inc. (OPGN) stock surged during pre-market session. What’s driving it high?

Opgen Inc. (NASDAQ: OPGN) stock declined by 1.84% at the last close whereas the OPGN stock price gains by 22.07% in the pre-market trading...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam